Masato Takahashi
Sapporo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 163 publications
A Twin-Fluid Atomization Method for Fabricating Ovalbumin-Loaded Gelatin Microcapsules.
Journal: Chemical & pharmaceutical bulletin
Published: May 27, 2026
Cytokine Release Syndrome Induced by Neoadjuvant Pembrolizumab in Early Triple-Negative Breast Cancer: A Case Report with Implications for Early Diagnosis and Management.
Journal: Case reports in oncology
Published: April 18, 2026
ASO Visual Abstract: Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer-Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study.
Journal: Annals of surgical oncology
Published: March 12, 2026
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 25, 2026
Minimal important differences of EORTC QLQ-C30 and QLQ-BR23 for metastatic breast cancer patients in a Japanese population: results from the RESQ trial.
Journal: Breast cancer (Tokyo, Japan)
Published: February 12, 2026
Health-related quality of life with pertuzumab retreatment: Secondary analysis of the PRECIOUS trial.
Journal: Breast (Edinburgh, Scotland)
Published: November 19, 2025
Radiofrequency Ablation for Early Stage Breast Cancer as a Potential Alternative to Partial Mastectomy: 5-Year Results from the Multiple-Center, Single-Arm, Phase 3 RAFAELO Study (NCCH1409).
Journal: Annals of surgical oncology
Published: October 28, 2025
Isolation and evaluation of candidate plant-protecting bacteria from rice seedlings asymptomatic to Burkholderia glumae infection.
Journal: Scientific reports
Published: October 11, 2025
Three cases of whole breast irradiation for breast cancer in patients with Lymphangioleiomyomatosis (LAM).
Journal: Breast cancer (Tokyo, Japan)
Published: October 07, 2025
Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer: Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study.
Journal: Annals of surgical oncology
Published: October 03, 2025
Long-term outcomes of eribulin‑based neoadjuvant chemotherapy for triple‑negative breast cancer patients stratified by homologous recombination deficiency status: results of the randomized JBCRG-22 study.
Journal: Breast cancer research and treatment
Published: September 12, 2025
Last Updated: 09/26/2026